- Home
- LPTH vs NSPR Comparison
LPTH vs NSPR Comparison
Compare LPTH & NSPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LPTH
- NSPR
- Stock Information
- Founded
- LPTH 1985
- NSPR 2005
- Country
- LPTH United States
- NSPR United States
- Employees
- LPTH N/A
- NSPR N/A
- Industry
- LPTH Semiconductors
- NSPR Medical/Dental Instruments
- Sector
- LPTH Technology
- NSPR Health Care
- Exchange
- LPTH Nasdaq
- NSPR Nasdaq
- Market Cap
- LPTH 81.1M
- NSPR 75.6M
- IPO Year
- LPTH 1996
- NSPR N/A
- Fundamental
- Price
- LPTH $1.90
- NSPR $2.62
- Analyst Decision
- LPTH Strong Buy
- NSPR Strong Buy
- Analyst Count
- LPTH 3
- NSPR 2
- Target Price
- LPTH $4.67
- NSPR $4.75
- AVG Volume (30 Days)
- LPTH 107.1K
- NSPR 65.0K
- Earning Date
- LPTH 05-08-2025
- NSPR 05-13-2025
- Dividend Yield
- LPTH N/A
- NSPR N/A
- EPS Growth
- LPTH N/A
- NSPR N/A
- EPS
- LPTH N/A
- NSPR N/A
- Revenue
- LPTH $32,158,517.00
- NSPR $7,009,000.00
- Revenue This Year
- LPTH $16.90
- NSPR $28.93
- Revenue Next Year
- LPTH $52.77
- NSPR $172.18
- P/E Ratio
- LPTH N/A
- NSPR N/A
- Revenue Growth
- LPTH N/A
- NSPR 12.96
- 52 Week Low
- LPTH $1.04
- NSPR $1.81
- 52 Week High
- LPTH $4.42
- NSPR $3.80
- Technical
- Relative Strength Index (RSI)
- LPTH 35.13
- NSPR 38.94
- Support Level
- LPTH $2.03
- NSPR $2.57
- Resistance Level
- LPTH $2.24
- NSPR $2.71
- Average True Range (ATR)
- LPTH 0.17
- NSPR 0.17
- MACD
- LPTH 0.01
- NSPR -0.02
- Stochastic Oscillator
- LPTH 19.35
- NSPR 34.55
About LPTH LightPath Technologies Inc.
LightPath Technologies Inc is a manufacturer, distributor, and integrator of proprietary optical components and assemblies. It is also engaged in the research and development for optical solutions for the traditional optics markets and communications markets. The company's business based on the following product groups: precision molded optics, specialty products, and infrared products. It currently serves the following major markets, distribution and catalog, laser, industrial, instrumentation, telecommunications, and defense.
About NSPR InspireMD Inc.
InspireMD Inc is a United States based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System (MGuard Prime EPS). It generates the majority of the revenue from the sales of CGuard EPS which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The group operates in Italy, Germany, Russia and other countries.